Quick Answer
BIODESIX INC reported Operating Income of -$27.87 million for fiscal year 2025.
BIODESIX INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$27.87M | +19.2% |
| 2024 | -$34.50M | +16.6% |
| 2023 | -$41.34M | +18.3% |
| 2022 | -$50.59M | -23.6% |
| 2021 | -$40.94M | -78.5% |
| 2020 | -$22.93M | +14.2% |
| 2019 | -$26.74M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$7.05M | +17.9% | +27.5% |
| June 30, 2025 | -$9.72M | -18.0% | -6.4% |
| March 31, 2025 | -$9.14M | +17.1% | -6.3% |
| September 30, 2024 | -$8.59M | -19.8% | -4.3% |
| June 30, 2024 | -$8.24M | +24.6% | +25.3% |
| March 31, 2024 | -$11.02M | +32.7% | -53.7% |
| September 30, 2023 | -$7.17M | +32.4% | +34.4% |
| June 30, 2023 | -$10.93M | +6.0% | +33.3% |
- BIODESIX INC showed an increase of +19.2% in Operating Income compared to the prior fiscal year.
- Over the 2019–2025 period, BIODESIX INC’s operating income has declined by 4.2% (from -$26.74 million to -$27.87 million).
- The most recent figure is from BIODESIX INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: